Higher risk of short term COVID-19 vaccine adverse events in myositis patients with autoimmune comorbidities: results from the COVAD study

Dey M;R N;Nikiphorou E;Sen P;Saha S;Lilleker JB;Agarwal V;Kardes S;Day J;Milchert M;Joshi M;Gheita T;Salim B;Velikova T;Gracia-Ramos AE;Parodis I;Selva O'Callaghan A;Kim M;Chatterjee T;Tan AL;Makol A;Nune A;Cavagna L;Saavedra MA;Shinjo SK;Ziade N;Knitza J;Kuwana M;Distler O;Barman B;Singh YP;Ranjan R;Jain A;Pandya SC;Pilania RK;Sharma A;Manoj MM;Gupta V;Kavadichanda CG;Patro PS;Ajmani S;Phatak S;Goswami RP;Chowdhury AC;Mathew AJ;Shenoy P;Asranna A;Bommakanti KT;Shukla A;Pande AR;Chandwar K;Pauling JD;Wincup C;Üsküdar Cansu D;Zamora Tehozol EA;Rojas Serrano J;García-De La Torre I;Del Papa N;Sambataro G;Fabiola A;Govoni M;Parisi S;Bartoloni Bocci E;Sebastiani GD;Fusaro E;Sebastiani M;Quartuccio L;Franceschini F;Sainaghi PP;Orsolini G;De Angelis R;Danielli MG;Venerito V;Traboco LS;Hoff LS;Kusumo Wibowo SA;Tomaras S;Langguth D;Limaye V;Needham M;Srivastav N;Yoshida A;Nakashima R;Sato S;Kimura N;Kaneko Y;Loarce-Martos J;Prieto-González S;Gil-Vila A;Gonzalez RA;Chinoy H;Agarwal V;Aggarwal R;Gupta L;COVAD Study Group.

2023-01-01